And one of the stocks in this sector is flashing a buy signal now.
Read MoreThe recent pullback in these 5 top stocks is giving investors a great opportunity to buy now.
Read MoreAnd the firm says we could see the stock more than 26% higher over the next twelve months.
Read MoreInvestors beware: the VIX looks like it’s about to skyrocket higher.
Read MoreWhen technical traders see a stock’s price pattern diverging from its industry or sector, the question becomes whether that divergence represents an opportunity, or a risk. The commonly held principle that “a rising tide lifts all ships” usually means that if a broad segment of the market, such as the Consumer Discretionary sector, is performing […]
Read MoreTrade Setup Buy Target $5.29 Sell Target $6.07 Trailing Stop 20% Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company offers vopratelimab, a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid […]
Read More